Ligand Pharmaceuticals
LGND
LGND
346 hedge funds and large institutions have $5.3B invested in Ligand Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 124 increasing their positions, 130 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
346
Holders Change
+20
Holders Change %
+6.13%
% of All Funds
7.93%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.3%
New
41
Increased
124
Reduced
130
Closed
19
Calls
$27.5M
Puts
$19.4M
Net Calls
+$8.07M
Net Calls Change
+$11.2M
Top Buyers
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$44.1M |
| 2 |
DMK
David M. Knott
|
-$43.3M |
| 3 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$29M |
| 4 |
IAM
Impax Asset Management
Portsmouth,
New Hampshire
|
-$16.2M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$16.1M |